Company Filing History:
Years Active: 2025
Title: Innovations by Cory Ahonen in Cancer Treatment
Introduction
Cory Ahonen is an accomplished inventor based in Lebanon, NH (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 4 patents to his name, Ahonen is recognized for his dedication to advancing medical science.
Latest Patents
Cory Ahonen's latest patents include groundbreaking compositions for treating cancer. One of his notable inventions involves recombinant particles that are specifically designed to deliver chimeric antigen receptors to immune effector cells in vivo. This innovative approach aims to enhance the effectiveness of cancer therapies. Additionally, he has developed compositions comprising antigen binding polypeptides, which include antibodies or antigen binding fragments, along with nucleic acids encoding these polypeptides and vectors for their expression.
Career Highlights
Ahonen is currently associated with Kelonia Therapeutics, Inc., where he continues to push the boundaries of cancer research. His work is pivotal in developing new therapeutic strategies that could potentially transform cancer treatment.
Collaborations
Cory collaborates with talented individuals in his field, including Kevin M Friedman and Molly R Perkins. These partnerships enhance the innovative capacity of his research and contribute to the success of their projects.
Conclusion
Cory Ahonen's contributions to cancer treatment through his patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in therapeutic strategies for cancer patients.